Paper7973170
Smear-negative pulmonary tuberculosis.
Dutt AK and 1 other. Semin Respir Infect, 1994. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Smear-negative pulmonary tuberculosis. Papers, record 7973170. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7973170
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antitubercular Agents | Major topic |
| Mycobacterium tuberculosis | Major topic |
| Sputum | Major topic |
| Tuberculosis, Pulmonary | Major topic |
| Drug Administration Schedule | |
| Drug Therapy, Combination | |
| Humans | |
| Time Factors | |
| Tuberculin Test |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39368055 | Diagnostic Value of Targeted Next-generation Sequencing in Pulmonary Mycobacterial Infections. | Curr Med Sci | 2024 | https://conductscience.org/library/papers/39368055 | PubMed |
| 37908762 | Proteomic analyses of smear-positive/negative tuberculosis patients uncover differential antigen-presenting cell activation and lipid metabolism. | Front Cell Infect Microbiol | 2023 | https://conductscience.org/library/papers/37908762 | PubMed |
| 33264288 | Trade-offs between cost and accuracy in active case finding for tuberculosis: A dynamic modelling analysis. | PLoS Med | 2020 | https://conductscience.org/library/papers/33264288 | PubMed |
| 31986571 | Clinical Features and Outcomes of Tuberculosis in Inflammatory Bowel Disease Patients Treated with Anti-tumor Necrosis Factor Therapy. | Korean J Gastroenterol | 2020 | https://conductscience.org/library/papers/31986571 | PubMed |
| 29892144 | Frequency of Smear-Negative Tuberculosis in Northwest Iran. | Iran J Med Sci | 2018 | https://conductscience.org/library/papers/29892144 | PubMed |
| 26425292 | Management of pulmonary tuberculosis in health clinics in the Gombak district: How are we doing so far? | Malays Fam Physician | 2015 | https://conductscience.org/library/papers/26425292 | PubMed |
| 25105410 | Culture conversion rate at 2 months of treatment according to diagnostic methods among patients with culture-positive pulmonary tuberculosis. | PLoS One | 2014 | https://conductscience.org/library/papers/25105410 | PubMed |
| 20931028 | Study of bronchoalveolar lavage in clinically and radiologically suspected cases of pulmonary tuberculosis. | Lung India | 2010 | https://conductscience.org/library/papers/20931028 | PubMed |
| 8736627 | Tuberculosis in the elderly. Epidemiology and optimal management. | Drugs Aging | 1996 | https://conductscience.org/library/papers/8736627 | PubMed |
| 8707321 | Occult miliary tuberculosis in advanced HIV disease. | Genitourin Med | 1996 | https://conductscience.org/library/papers/8707321 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7973170
GET https://conductscience.org/api/papers/v1/7973170/authors